Comparing Intermittent To Continuous Androgen Deprivation For Advanced Prostate Cancer

A recent Finnish study released interim results comparing intermittent androgen deprivation (IAD) to continuous androgen deprivation (CAD) in 856 men. All the men had locally advanced or metastatic prostate cancer and they all were treated at 27 clinics in Finland. The period of study was between 1997 and 2003 and all men were required to [...]

Dendreon (Provenge) Initiates Second of Two New Phase 2 Trials

Dendreon Corporation (Nasdaq: DNDN), the company that is testing Provenge a potential vaccine for prostate cancer, has started a second of two new Phase 2 trials. The multicenter trial, called ProACT (PROstate Active Cellular Therapy), is enrolling 120 men with metastatic, androgen independent prostate cancer. The trial protocol calls for all men to receive active [...]

One Blood Test and Four Different Options

In addition to the three cancers, I also have an arthritic condition. My rheumatologist has prescribed certain medications that require regular monitoring for liver damage, so every six weeks I go into the lab to have a complete blood panel along with my PSA. Included in the blood panel are also some kidney screens. One [...]

A Phase II Trial, A New Type Of Vaccine For Prostate Cancer

I have to admit that cancer researchers are becoming very creative. There is a phase II clinical trial getting ready to start at the Wake Forest University Baptist Medical Center which has a new twist. The treatment is based on injecting white blood cells called 'cancer killing' granulocytes from healthy donors into cancer survivors with [...]

Go to Top